Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Russo, M; Saitto, G; Lio, A; Di Mauro, M; Berretta, P; Taramasso, M; Scrofani, R; Della Corte, A; Sponga, S; Greco, E; Saccocci, M; Calafiore, A; Bianchi, G; Biondi, A; Binaco, I; Della Ratta, E; Livi, U; Werner, P; De Vincentiis, C; Ranocchi, F; Di Eusanio, M; Kocher, A; Antona, C; Miraldi, F; Troise, G; Solinas, M; Maisano, F; Laufer, G; Musumeci, F; Andreas, M.
Observed versus predicted mortality after isolated tricuspid valve surgery
J CARDIAC SURG. 2022; 37(7): 1959-1966.
Doi: 10.1111/jocs.16483
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Andreas Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Background Aim of this study is to analyse the performances of Clinical Risk Score (CRS) and European System for Cardiac Operative Risk Evaluation (EuroSCORE)-II in isolated tricuspid surgery. Methods Three hundred and eighty-three patients (54 +/- 16 year; 54% female) were enrolled. Receiver operating characteristic analysis was performed to evaluate the relationship between the true positive fraction of test results and the false-positive fraction for a procedure. Results Considering the 30-day mortality the area under the curve was 0.6 (95% confidence interval [CI] 0.50-0.72) for EuroSCORE II and 0.7 (95% CI 0.56-0.84) for CRS-score. The ratio of expected/observed mortality showed underestimation when considering EuroSCORE-II (min. 0.46-max. 0.6). At multivariate analysis, the CRS score (p = .005) was predictor of late cardiac death. Conclusion We suggest using both scores to obtain a range of expected mortality. CRS to speculate on late survival.
- Find related publications in this database (Keywords)
-
valve repair
-
replacement